ACTA1 and breast carcinoma: To validate the sequential progression of breast cancer, we investigated the status of molecular markers of proliferation and invasion, such as a proliferating cell nuclear antigen (PCNA) [63] and α-SMA in different paraffin-embedded tissue sections using immunohistochemical analysis.